THE BET PROTEIN INHIBITOR APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DIABETES: RESULTS FROM THE BETONMACE TRIAL

被引:0
|
作者
Sweeney, Michael
Nicholls, Stephen J.
Ray, Kausik Kumar
Buhr, Kevin
Ginsberg, Henry
Johansson, Jan
Kalantar-Zadeh, Kamyar
Kulikowski, Ewelina
Toth, Peter
Wong, Norman
Schwartz, Gregory G.
机构
[1] Imperial Coll, London, England
[2] Resverlogix Corp, Calgary, AB, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1315-168
引用
收藏
页码:168 / 168
页数:1
相关论文
共 50 条
  • [41] Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome
    Xavier Rossello
    João Pedro Ferreira
    Francisca Caimari
    Zohra Lamiral
    Abhinav Sharma
    Cyrus Mehta
    George Bakris
    Christopher P. Cannon
    William B. White
    Faiez Zannad
    Clinical Research in Cardiology, 2021, 110 : 1612 - 1624
  • [42] Incidence, predictors and prognostic implications of dyspnea at admission among acute coronary syndrome patients without heart failure
    Marcus, G.
    Shimony, S.
    Stein, G. Y.
    Matezky, S.
    Iakobishvili, Z.
    Minha, S.
    Fuchs, S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 301 : 29 - 33
  • [43] PROCALCITONIN IDENTIFIES ACUTE HEART FAILURE BIOMARKERS IN PATIENTS WITH ACUTE HEART FAILURE IN NEED OF ANTIBIOTIC THERAPY: OBSERVATIONAL RESULTS FROM THE BACH (BIOMARKERS IN ACUTE HEART FAILURE) TRIAL
    Hartmann, O.
    Landsberg, J.
    Mueller, C.
    Nowak, R.
    Ponikowski, P.
    Moeckel, M.
    Hogan, C.
    Wu, A. H. B.
    Richards, M.
    Filippatos, G. S.
    Di Somma, S.
    Anand, I. S.
    Ng, L.
    Neath, S. X.
    Christenson, R.
    McCord, J.
    Morgenthaler, N. G.
    Engineer, R.
    Bergmann, A.
    Anker, S. D.
    Maisel, A. S.
    Peacock, F. W.
    THORAX, 2009, 64 : A62 - A62
  • [44] Deleterious synergistic effects of acute heart failure and diabetes mellitus in patients with acute coronary syndrome: Data from the FAST-MI Registries
    Dillinger, Jean-Guillaume
    Achkouty, Guy
    Albert, Franck
    Muller, Gregoire
    Labeque, Jean-Noel
    Moisson, Louis
    Morelle, Jean-Francois
    Cottin, Yves
    Pezel, Theo
    Lim, Pascal
    Aissaoui, Nadia
    Schiele, Francois
    Ferrieres, Jean
    Angoulvant, Denis
    Henry, Patrick
    Puymirat, Etienne
    Simon, Tabassome
    Danchin, Nicolas
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2022, 115 (05) : 264 - 275
  • [45] Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure
    Steg, Philippe Gabriel
    Kerner, Arthur
    de Werf, Frans Van
    Lopez-Sendon, Jose
    Gore, Joel M.
    FitzGerald, Gordon
    Feldman, Laurent J.
    Anderson, Frederick A.
    Avezum, Alvaro
    CIRCULATION, 2008, 118 (11) : 1163 - 1171
  • [46] Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes A Randomized Clinical Trial
    Ray, Kausik K.
    Nicholls, Stephen J.
    Buhr, Kevin A.
    Ginsberg, Henry N.
    Johansson, Jan O.
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Sweeney, Michael
    Schwartz, Gregory G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16): : 1565 - 1573
  • [47] Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial
    Sharma, Abhinav
    Vaduganathan, Muthiah
    Ferreira, Joao Pedro
    Liu, Yuyin
    Bakris, George L.
    Cannon, Christopher P.
    White, William B.
    Zannad, Faiez
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (01):
  • [48] BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
    Sylwia Wasiak
    Kim E. Dzobo
    Brooke D. Rakai
    Yannick Kaiser
    Miranda Versloot
    Mahnoush Bahjat
    Stephanie C. Stotz
    Li Fu
    Michael Sweeney
    Jan O. Johansson
    Norman C. W. Wong
    Erik S. G. Stroes
    Jeffrey Kroon
    Ewelina Kulikowski
    Clinical Epigenetics, 2020, 12
  • [49] Impact of revascularization on outcomes in patients with non ST-elevation acute coronary syndrome and congestive heart failure. The Global Registry of Acute Coronary Events (GRACE)
    Kerner, A.
    Fitzgerald, G.
    Van de Werf, F. F.
    Feldman, L. J.
    Lopez-Sendon, J.
    Gore, J. M.
    Anderson, A.
    Avezum, A.
    Steg, P. G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 514 - 514
  • [50] Radiofrequency ablation of the AV junction improves functional status in patients with congestive heart failure: Results from the APT trial
    Ellenbogen, KA
    Kay, GN
    Giudici, M
    Redfield, MM
    Jenkins, L
    TakleNewhouse, T
    Jensen, DN
    Martin, RC
    CIRCULATION, 1996, 94 (08) : 3984 - 3984